Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > 中和抗体

InVivoMAb Anti-Human Angiopoietin-like Protein 3/ANGPTL3 Antibody (Iv0160) (HV176010)

InVivoMAb Anti-Human Angiopoietin-like Protein 3/ANGPTL3 Antibody (Iv0160)
InVivoMAb Anti-Human Angiopoietin-like Protein 3/ANGPTL3 Antibody (Iv0160)
価格(USD):
スペック:
  • 100ug
  • 1mg
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号HV176010
説明
InVivoMAb Anti-Human ANGPTL3 Antibody (Iv0160) [Iv0160] (HV176010) is a human monoclonal antibody detecting ANG-5 in ELISA, Neutralization. Suitable for Human, Mouse, and Rat.
Highlights
  • ●Multi-Species — Cross-reactive for translational research.
種反応性Human, Mouse, Rat
アプリケーションELISA, Neutralization
宿主種Human
クローン性Monoclonal
アイソタイプIgG4, kappa
クローンIDIv0160
ターゲット ANG-5, Angiopoietin-like protein 3, ANGPT5, Angiopoietin-5, ANGPTL3, Angiopoietin-related protein 3
エンドトキシンレベル Please contact with the lab for this information.
純度 >95% as determined by SDS-PAGE.
関連製品 pH 7.4 Dilution Buffer
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 Q9Y5C1
形態 Liquid
保存バッファー 0.01M PBS pH 7.4

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
背景

Angiopoietin-related protein 3 (ANGPTL3) is a ~53 kDa protein. Acts in part as a hepatokine that is involved in regulation of lipid and glucose metabolism. Proposed to play a role in the trafficking of energy substrates to either storage or oxidative tissues in response to food intake. Has a stimulatory effect on plasma triglycerides (TG), which is achieved by suppressing plasma TG clearance via inhibition of LPL activity. The inhibition of LPL activity appears to be an indirect mechanism involving recruitment of proprotein convertases PCSK6 and FURIN to LPL leading to cleavage and dissociation of LPL from the cell surface; the function does not require ANGPTL3 proteolytic cleavage but seems to be mediated by the N-terminal domain, and is not inhibited by GPIHBP1. Can inhibit endothelial lipase, causing increased plasma levels of high density lipoprotein (HDL) cholesterol and phospholipids.

1. Koishi, R. et al. (2002) Nature genetics 30, 151-7. PMID: 11788823
2. Ono, M. et al. (2003) The Journal of biological chemistry 278, 41804-9. PMID: 12909640
3. Robciuc, MR. et al. (2013) Arteriosclerosis, thrombosis, and vascular biology 33, 1706-13. PMID: 23661675
4. Tikka, A. et al. (2014) Bioscience reports 34, e00160. PMID: 25495645
5. Shimizugawa, T. et al. (2002) The Journal of biological chemistry 277, 33742-8. PMID: 12097324
6. Lee, EC. et al. (2009) The Journal of biological chemistry 284, 13735-13745. PMID: 19318355
7. Liu, J. et al. (2010) The Journal of biological chemistry 285, 27561-70. PMID: 20581395
8. Shimamura, M. et al. (2007) Arteriosclerosis, thrombosis, and vascular biology 27, 366-72. PMID: 17110602
9. Shan, L. et al. (2009) The Journal of biological chemistry 284, 1419-24. PMID: 19028676
10. Shimamura, M. et al. (2003) Biochemical and biophysical research communications 301, 604-9. PMID: 12565906
注意事項 For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
イメージ
  • InVivoMAb Anti-Human Angiopoietin-like Protein 3/ANGPTL3 Antibody (Iv0160)

    SDS-PAGE

    SDS-PAGE for InVivoMAb Anti-Human ANGPTL3 Antibody (Iv0160).

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト